[Discussion] Apotheke is doing more work than we give it credit for
The title is the argument: Apotheke is doing more work than we give it credit for. Here is the rest of it.
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
Not medical advice, obviously, and nothing here is approved for human use. One person with a spreadsheet.
best — the order this archive was captured in
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.
Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.
This is the split the whole board depends on. Authorisation is European; payment is national.
Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.
Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.
Yes.
milan_mensah is right about cross-border recognition being narrower than the summaries suggest.
That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.
That shortage notice was national and does not apply where the question is coming from.